相关实验视频

Updated: Jun 21, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

如何治疗局部化的霍奇金淋巴瘤?

Wivine Bernard¹, M André, G Crochet

¹CHU UCL Namur - Site Godinne, Yvoir, Belgium.

Current opinion in oncology

|July 15, 2024

概括

传统策略与新型免疫疗法相结合,对早期的古典霍奇金淋巴瘤显示出有前途. 新的预后标志物可能会指导治疗,但需要长期的疗效和安全性数据.

科学领域:

血液学血液学血液学
在瘤学瘤学.
临床试验临床试验

背景情况:

早期的古典霍奇金淋巴瘤治疗包括常规化疗和放射治疗.
免疫疗法和新的预后标志物正在成为重要的因素.

研究的目的:

审查关于早期古典霍奇金淋巴瘤管理的当前知识.
专注于传统策略,免疫疗法整合和新的预后标志物.

主要方法:

审查当前的文献和临床试验数据.
对联合模式治疗的长期结果的分析.
评估新型药物,如布伦图西马布维多丁和检查点抑制剂.

主要成果:

与单独的化疗相比,联合疗法治疗改善了无进展生存率.
新型药物在一线治疗中显示出有希望的结果.
临时PET扫描具有有限的预后价值;免疫疗法的作用尚不清楚.
代谢性瘤体积和循环瘤DNA是新兴的预后标志物.

结论:

免疫疗法已经准备好改变早期古典霍奇金淋巴瘤的前线管理.
需要新药的长期疗效和安全性数据.
新的预后标志物可以指导治疗决策,但需要进一步验证临床使用.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...